Product Image

Ginkgo Gotu Kola 275 mg

Eclectic Herb
4.7
★ ★ ★ ★ ★
(1122 ratings)
Ginkgo
Product Image
Score71
A clean whole-herb ginkgo and gotu-kola pairing, but modest amounts and absent active markers limit confidence.
How scoring works
Quantity:90 Capsule(s) • (90 servings)
Goals:
Brain Health
Productivity Boost
Cognitive Support
Mental Focus

Score 71

A clean whole-herb ginkgo and gotu-kola pairing, but modest amounts and absent active markers limit confidence.
How scoring works
$23.24($0.25 per serving)
iHerb
$ 23.24
iHerb
$ 23.24
Report prices

Analysis

The serving contains 175 mg of freeze-dried ginkgo leaf and 100 mg of gotu kola. Their shared traditional use in circulation and cognition gives the formula a clear theme without unrelated fillers.

Freeze-dried whole leaf is not equivalent to a standardized ginkgo extract, and no flavonglycoside, terpene-lactone, or ginkgolic-acid specification is supplied. Gotu kola also lacks an extract ratio or active-marker standardization.

The product may suit adults who prefer whole-herb preparations and accept a gentler, less predictable approach. It is not the strongest choice for dependable focus, broad vision nutrition, or comparison with clinically characterized ginkgo extracts.

Who is it for
  • Adults who prefer whole-herb cognitive products
  • People seeking a simple ginkgo and gotu-kola combination
Best for
  • Traditional botanical cognitive support
  • A focused two-herb routine

Pros

  • Uses freeze-dried ginkgo leaf
  • Includes gotu kola
  • Discloses both ingredient amounts
  • Keeps the formula simple

Cons

  • Ginkgo is not a standardized extract
  • No ginkgolic-acid limit is provided
  • Gotu kola is unstandardized
  • Amounts are modest for reliable effects

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.

Nutrient quality

68 High impact

Freeze-dried ginkgo and gotu kola form a coherent botanical pairing. Modest doses and absent active-marker standardization limit likely potency.

.

Ingredient transparency

74 High impact

All listed active amounts are disclosed without a hidden blend. Intake directions, inactive ingredients, and important extract details are not supplied.

.

Customer satisfaction

68 High impact

The supplied average rating is strong and comes from a substantial rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

71 High impact

The focused formula provides fair value at a moderate serving cost. Modest doses and absent standardization weaken competitiveness.

.
Report analysis

Goals

Brain Health
Impact
Moderate effect
B- Goal FitD Strength of SupportC CoverageA- Formula Quality

Ginkgo and gotu kola are relevant to circulation and traditional cognitive support. The freeze-dried whole-herb format lacks the standardized markers used in stronger ginkgo evidence.

Both herb amounts are disclosed, but flavone glycosides, terpene lactones, and ginkgolic acid limits are absent. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Impact
Moderate effect
D+ Goal FitF Strength of SupportD CoverageA Formula Quality

Ginkgo and gotu kola offer plausible support for mental clarity and circulation. The ginkgo is freeze-dried whole herb rather than the standardized extract used in stronger clinical evidence.

Amounts are transparent, but active-marker and purity specifications are missing. The formula is simple yet likely underpowered for a dependable productivity effect.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Cognitive Support
Impact
Moderate effect
D+ Goal FitF Strength of SupportD CoverageA- Formula Quality

Ginkgo and gotu kola target cerebral circulation and traditional memory support. Evidence is limited by whole freeze-dried ginkgo leaf and unstandardized gotu kola rather than clinically characterized extracts.

The whole-leaf ginkgo and modest gotu-kola amounts do not establish a clinically effective active dose. Amounts and plant identities are clear, but active markers, extract ratios, and ginkgolic-acid controls are absent. Ginkgo may increase bleeding risk when used with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Mental Focus
Impact
Moderate effect
C Goal FitF Strength of SupportF CoverageB Formula Quality

Ginkgo and gotu kola have traditional cognitive relevance, but the formula uses whole-herb material rather than a verified clinical extract. Direct focus effects are therefore uncertain.

Amounts are stated clearly, yet no active-marker or ginkgolic-acid specification is provided. The two-botanical formula is focused but lacks reliable dose depth and broader alertness support.

Study evidence
Ginkgo Supportive 28 studies

Ingredients

IngredientAmount per serving
Ginkgo biloba, Freeze-Dried
175 mg
Gotu Kola
100 mg
Gluten Free Adults 18–50 Vegan Kosher Vegetarian
Report overview
Ginkgo · 175 mg OverallScore25
F Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyF Value

Freeze-dried ginkgo leaf provides whole-herb material rather than a standardized extract. The amount is clearly disclosed, but active-marker and ginkgolic acid specifications are absent. The modest serving cost does not compensate for the lack of a verified clinical extract.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  2. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  3. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  4. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  5. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  6. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  7. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  8. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  9. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  10. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  11. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  12. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  13. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  14. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  15. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  16. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  17. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  18. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  19. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  20. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo